Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Resmed Inc shares valued at $845,700 were sold by Sandercock Brett on Aug 01 ’25. At $281.90 per share, Sandercock Brett sold 3,000 shares. The insider’s holdings dropped to 83,283 shares worth approximately $23.36 million following the completion of this transaction.
Also, Rider Michael J sold 50 shares, netting a total of over 14,095 in proceeds. Following the sale of shares at $281.90 each, the insider now holds 8,486 shares.
Before that, Rider Michael J had added 50 shares to its account. In a trade valued at $14,095, the Officer bought Resmed Inc shares for $281.90 each.
As published in a research note from RBC Capital Mkts on July 15, 2025, Resmed Inc [RMD] has been rated up from a Sector perform to an Outperform and the price target has been revised to $294. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. As of March 19, 2025, Morgan Stanley has initiated its “an Overweight” rating for RMD. Earlier on January 16, 2025, Goldman initiated its rating. Their recommendation was “a Buy” for RMD stock.
Analyzing RMD Stock Performance
On last trading session, Resmed Inc [NYSE: RMD] plunged -1.59% to $280.46. The stock’s lowest price that day was $279.45, but it reached a high of $285.49 in the same session. During the last five days, there has been a surge of approximately 1.09%. Over the course of the year, Resmed Inc shares have jumped approximately 25.41%.
Is Resmed Inc subject to short interest?
Stocks of Resmed Inc saw a sharp steep in short interest on 2025-07-15 dropping by -0.55 million shares to 9.38 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 9.93 million shares. A decline of -5.89% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 11.59 of the overall float, the days-to-cover ratio (short ratio) decline to 11.59.
Which companies own the most shares of Resmed Inc (RMD)?
In terms of Resmed Inc share price expectations, FactSet research, analysts set an average price target of 269.5 in the next 12 months, down nearly -5.44% from the previous closing price of $285.0. Analysts anticipate Resmed Inc stock to reach 286 by 2025, with the lowest price target being 240. In spite of this, 19 analysts ranked Resmed Inc stock as Buy at the end of 2025. On January 10, 2025, Piper Sandler assigned a price target of “a Neutral” to the stock and initiated coverage with a $252.
